1
/
of
3
Antigenic Swabs Rapid Nasal Swab All Variants Certificate 25 Pieces
Antigenic Swabs Rapid Nasal Swab All Variants Certificate 25 Pieces
Regular price
€53,90 EUR
Regular price
€58,90 EUR
Sale price
€53,90 EUR
Taxes included.
Shipping calculated at checkout.
Rapid test for the detection of SARS-CoV-2 nucleocapsid antigens in anterior nasal swab samples. For in vitro diagnostic use only. For self-testing.
The SARS-CoV-2 Rapid Antigen Test is a lateral flow immunoassay for the qualitative detection of nucleocapsid antigen from SARS-CoV-2 in anterior nasal swab samples directly from individuals suspected of COVID-19 within the first seven days of symptom onset. The test can be used to analyze samples from asymptomatic subjects. It does not differentiate between SARS-CoV and SARS-CoV-2. Results are for the identification of SARS-CoV-2 antigen. This antigen is generally found in samples collected from the upper respiratory tract during the acute phase of infection. Positive results indicate the presence of viral antigens, but medical history and other personal diagnostics are necessary to determine the infection status. Positive results do not rule out bacterial infections or co-infection with other viruses. The detected pathogen may not be the exact cause of the illness. Negative results obtained from subjects with symptoms that appeared more than seven days ago should be treated as probable negatives. If necessary, seek confirmation through molecular analysis. Negative results do not rule out SARS-CoV-2 infection. The SARS-CoV-2 rapid antigen test is intended for use as an aid in the diagnosis of SARS-CoV-2 infection. The usability of self-tests performed by individuals under 18 years of age has not been determined. It is advisable that minors under 18 years of age be tested by an adult.The SARS-CoV-2 rapid antigen test is a test for the detection of nucleocapsid antigen from SARS-CoV-2 in human anterior nasal swab samples. Test results are read visually within the subsequent 15-30 minutes, based on the presence or absence of colored lines. A colored line serving as a procedural control will always appear in the control line area, to indicate that a sufficient sample volume has been added and that membrane absorption has occurred.
ATTENTION:
The Customer expressly declares, by confirming the order, that they are aware that this product is classified as an In Vitro Diagnostic Device (IVD) intended exclusively for professional use, and therefore declares, under their own responsibility and aware of the civil and criminal consequences arising from untruthful declarations, to be a healthcare professional authorized to use the tests or that the purchased diagnostic device will be used exclusively by authorized healthcare personnel in the context of health surveillance.Aware of the criminal penalties referred to in Article 76 of Presidential Decree 28/12/00 no. 445 in the case of false declarations and the forfeiture of any benefits resulting from the measure issued on the basis of untruthful declarations, as per Article 75 of Presidential Decree no. 445 of 28/12/00; pursuant to and for the purposes of Article 47 of the aforementioned Presidential Decree 445/2000; the customer hereby releases RAM Apparecchi Medicali srl from any civil, criminal or administrative liability.
The REAGEN COVID-19 antigen test is a lateral flow immunoassay method for the qualitative detection of SARS CoV-2 nucleocapsid antigen in nasopharyngeal and oropharyngeal swabs from individuals suspected of being infected with COVID-19.
The results are for the detection of SARS CoV-2 nucleocapsid antigen.
The antigen is generally detectable in nasopharyngeal (NASAL) and oropharyngeal (ORAL) swabs during the acute phase of infection.
Share
